نتایج جستجو برای: diphtheria toxoid purification and characterization

تعداد نتایج: 16903098  

Journal: :Nippon Saikingaku Zasshi 1950

Journal: :The Journal of infectious diseases 1996
R K Gupta P Griffin J Xu R Rivera C Thompson G R Siber

Plasma samples from 500 blood donors were titrated for diphtheria antitoxin (DAT) by the toxin neutralization (TN) test. Only 1.6% of donors had <0.01 IU/mL DAT, the minimum protective level against diphtheria; 15% had levels between 0.01 and <0.1 IU/mL, indicating basic protection, and 83.4% had levels > or =0.1 IU, indicating full protection. Three hundred fifty samples were studied by ELISA ...

Journal: :The Journal of Experimental Medicine 1957
Jonathan W. Uhr Matthew Scharff

Guinea pigs infected by intradermal injection of living toxigenic diphtheria bacilli and protected by horse antitoxic globulin, given either before or after infection, develop delayed hypersensitivity of the tuberculin type to diphtherial proteins. The highest degree of hypersensitivity is specifically directed against diphtheria toxin (or toxoid) itself, although smaller delayed skin reactions...

Journal: :The Journal of the American Osteopathic Association 2011
Jeffrey T Kirchner

Despite the availability of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in the United States since 2005, the vaccine remains underutilized and perhaps misunderstood by many physicians. Pertussis continues to be a major public health problem, with adults being the primary source of infectious transmission to unprotected infants. Consequently, the Centers f...

Journal: :Vaccine 1999
M Isaka Y Yasuda S Kozuka T Taniguchi K Matano J Maeyama T Komiya K Ohkuma N Goto K Tochikubo

Nasal mucosal immunization is very attractive for vaccination to prevent various bacterial and viral infectious diseases because of induction of systemic and mucosal immune responses. The aim of the present study was to investigate the possibility of changing the immunization procedure of diphtheria toxoid (DT) from intramuscular or subcutaneous injection to intranasal administration. Intranasa...

2018
Camila Azevedo Antunes Emily J Richardson Joshua Quick Pablo Fuentes-Utrilla Georgia L Isom Emily C Goodall Jens Möller Paul A Hoskisson Ana Luiza Mattos-Guaraldi Adam F Cunningham Nicholas J Loman Vartul Sangal Andreas Burkovski Ian R Henderson

The genome sequence of the human pathogen Corynebacterium diphtheriae bv. mitis strain ISS 3319 was determined and closed in this study. The genome is estimated to have 2,404,936 bp encoding 2,257 proteins. This strain also possesses a plasmid of 1,960 bp.

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011
B A Halperin A Morris D Mackinnon-Cameron J Mutch J M Langley S A McNeil D Macdougall S A Halperin

BACKGROUND Because adolescents and adults act as a primary source of pertussis infection for infants, vaccination of mothers immediately postpartum is a potential strategy to reduce transmission (cocoon strategy). For this to be effective, high levels of antibodies must be achieved rapidly after vaccination. We sought to determine whether the antibody response to tetanus-diphtheria-acellular pe...

Journal: :The Journal of biological chemistry 1948
R G WITTLER L PILLEMER

The success encountered in the purification of tetanal toxin (1) and toxoid (2, 3), of diphtherial toxoid (4), and of soluble pertussal antigens (5) warranted attempts to purify other toxins and toxoids by the multiphase system of protein fractionation. The system employs the precise adjustment of methanol concentration, pH, ionic strength, and protein concentration under rigidly controlled con...

Journal: :Infection and immunity 2001
E N Miyaji R P Mazzantini W O Dias A L Nascimento R Marcovistz D S Matos I Raw N Winter B Gicquel R Rappuoli L C Leite

BCG, the attenuated strain of Mycobacterium bovis, has been widely used as a vaccine against tuberculosis and is thus an important candidate as a live carrier for multiple antigens. With the aim of developing a recombinant BCG (rBCG) vaccine against diphtheria, pertussis, and tetanus (DPT), we analyzed the potential of CRM(197), a mutated nontoxic derivative of diphtheria toxin, as the recombin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید